Description

Semaglutide Powder

Semaglutide is a medication that was approved by the U.S. Food and Drug Administration (FDA) in June 2021 for weight loss. It is combined with a low-calorie diet and exercise program to help people lose weight.

Semaglutide is a GLP-1 agonist that works by increasing insulin release, decreasing glucagon release, delaying gastric emptying, and reducing appetite. Semaglutide is not suitable for people with type 1 diabetes.

Semaglutide Powder information

Name: Semaglutide
CAS No.: 910463-68-2
Peptide Sequence: His-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys(AEEA-AEEA-Glu-17-carboxyheptadecanoyl)-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly-OH
Molecular Formula: C187H291N45O59
Molecular Weight: 4113.64
Appearance: White Lyophilized powder
Synonyms: Semaglutide, Wegovy, Ozempic, Rybelsus

Disclaimer: For Research Purposes Only

This content is provided strictly for research purposes and does not constitute an endorsement or recommendation for the non-laboratory application or improper handling of peptides designed for research. The information, including discussions about specific peptides and their researched benefits, is presented for informational purposes only and must not be construed as health, clinical, or legal guidance, nor an encouragement for non-research use in humans.

Peptides described here are solely for use in structured scientific study by authorized individuals. Any deviation or unauthorized use could lead to legal and health implications. We advise consulting with research experts, medical practitioners, or legal counsel prior to any decisions about obtaining or utilizing these peptides. The expectation of responsible, ethical utilization of this information for legitimate investigative and scholarly objectives is paramount. This notice is dynamic and governs all provided content on research peptides.

Weight Loss and Blood Sugar Control 

Overview: Semaglutide is a medication primarily used for the treatment of type 2 diabetes, known for its ability to regulate blood sugar levels. It functions as a GLP-1 receptor agonist, enhancing insulin secretion and decreasing glucagon production, thereby improving glycemic control. Recently, semaglutide has also gained attention for its effectiveness in weight management, showing significant results in reducing body weight in clinical studies. Its administration is typically through subcutaneous injections, making it a convenient option for patients seeking improved diabetes management and weight loss.

Impact: Semaglutide is know for enhancing insulin production and reducing glucagon secretion. This action helps lower blood sugar levels and improves overall glycemic control in patients.

Safety: Semaglutide is generally well-tolerated, but it can cause gastrointestinal side effects such as nausea, vomiting, and diarrhea, particularly when treatment begins. Users may also experience a reduced appetite and potential risk of low blood sugar, especially when combined with other diabetes medications. It’s important for patients to closely monitor their health and consult with healthcare providers to ensure safe and effective use of semaglutide, particularly those with preexisting conditions or taking other medications.